The meeting allowed him to see firsthand “La Casa de los Científicos” (The Scientists' House), a cutting-edge headquarters of more than 4,000 m² inaugurated in 2025 that symbolizes the success of the cooperative model applied to high technology.
Since its constitution in 2013, i+Med has established itself as a leader in the field of smart nanohydrogels and the controlled release of drugs, a technology designed to administer medication into the body through microscopic structures capable of controlling how and when the active ingredient acts, taking into account the personal needs of the patient.I
More than 100 scientists and researchers
But in addition to its advances in biomedicine, a distinctive element of this entity is its legal formula. It is a cooperative made up of more than 100 scientists and researchers who contribute their talent in critical areas such as traumatology, aesthetic medicine, ophthalmology, and dermatology.
Those in charge of the cooperative explain that “i+Med was born with the objective of putting science and people at the center, ahead of the financial ratio” and they ensure that to achieve this, "the key is to place science and the people who generate knowledge at the heart of the company, hence our cooperative model."
This philosophy, which balances profitability with human well-being, reinforces the cooperative model as a path of excellence for medical research. i+Med demonstrates that collective talent and research vocation are magnificent allies to improve the quality of life of patients.
